Stritinib 400 mg Tablet
  1. Home
  2. Pharma Products
  3. Mylan Pharmaceuticals Pvt Ltd
  4. Stritinib 400 mg Tablet

Stritinib 400 mg Tablet

Stritinib 400 mg Tablet contains imatinib 400 mg, a targeted anticancer medicine belonging to the tyrosine kinase inhibitor group. It is used to treat chronic myeloid leukemia, certain acute lymphoblastic leukemia cases, and gastrointestinal stromal tumors. The tablet is taken orally under the supervision of a qualified healthcare professional.

BUY NOW

Category

Imatinib works by blocking specific abnormal tyrosine kinase signals that promote the growth and survival of cancer cells. It may also be prescribed for other approved conditions such as dermatofibrosarcoma protuberans. Regular blood counts and clinical monitoring are important during treatment to assess response and detect adverse effects. The dose and treatment duration are determined according to the specific disease and the patient’s response to therapy.

Technical Specification

Specification Details
Active Ingredient Imatinib
Strength 400 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 Tablets
Marketer Mylan Pharmaceuticals Pvt Ltd

Product Also Known As

Stritinib 400 mg Tablet, Stritinib 400mg Tablet, Stritinib 400 Tablet, Imatinib 400 mg Tablet, Imatinib 400mg Tablet, Imatinib Mesylate 400 mg Tablet, Imatinib Anticancer Tablet